Follow Chr. Hansen A/S

Press releases View all 408 hits

Chr. Hansen’s Head of Sustainability recognized as Meaningful Business 100 Leader

Chr. Hansen’s Head of Sustainability recognized as Meaningful Business 100 Leader

Press releases   •   Nov 06, 2019 12:09 UTC

Global platform brings together the top 100 business leaders who are combining profit and purpose to help achieve the UN Sustainable Development Goals

Chr. Hansen reaches 7% organic growth in 2018/19

Chr. Hansen reaches 7% organic growth in 2018/19

Press releases   •   Oct 10, 2019 06:28 UTC

Despite more challenging growth conditions Chr. Hansen delivers a strong EBIT margin and a healthy cash flow, while also making significant progress on key strategic priorities

Chr. Hansen’s good bacteria to be produced on solar power

Chr. Hansen’s good bacteria to be produced on solar power

Press releases   •   Sep 23, 2019 08:07 UTC

A new 10-year agreement enables Chr. Hansen Denmark to switch 100% to green power from two brand new solar parks. The agreement underlines Chr. Hansen’s commitment to a sustainable future and will create more green energy capacity to the benefit of all of Denmark.

Chr. Hansens gode bakterier skal fremstilles på solenergi

Chr. Hansens gode bakterier skal fremstilles på solenergi

Press releases   •   Sep 23, 2019 08:02 UTC

En ny tiårig aftale med Better Energy betyder, at Chr. Hansen kan overgå 100% til grøn strøm fra to helt nye solcelleparker. Aftalen understreger Chr. Hansens dedikation til en bæredygtig fremtid og skaber mere grøn energi til hele Danmark.

News 1 hit

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

News   •   Aug 29, 2019 09:16 UTC

​Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce today that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint venture in the emerging market for live biotherapeutic products, which was originally announced in Company Announcement No. 04 on April 2, 2019.

Images View all 14 hits

Knud Vindfeldt

Knud Vindfeldt

License Creative Commons Attribution
Download
Size

259 KB • 900 x 514 px

Chr. Hansen probiotics

Chr. Hansen probiotics

License Creative Commons Attribution
Photographer / Source Chr. Hansen
Download
Size

11.1 MB • 4872 x 6496 px

Caelus logo

Caelus logo

License Creative Commons Attribution
Download
Size

113 KB • 1193 x 1224 px

World Beverage Innovation FeelGood Kefir

Videos 2 hits

Ultra Stable Red

Ultra Stable Red

Chr. Hansen introduces the most stable natural red colors for beverages on the market. No longer should beverage producers accept fading,...

License Creative Commons Attribution
Download
Size

65.6 MB • 800 x 450 px

Yogurt - Cultures & Enzymes Division - Chr. Hansen A/S

Yogurt - Cultures & Enzym...

We develop and produce cultures, enzymes and probiotics for the dairy industry in particular and for the food industry in general -- e.g....

License Creative Commons Attribution
Download
Size

64.5 MB • 800 x 450 px

Documents View all 5 hits

FeelGood Kefir brochure

FeelGood Kefir brochure

Documents   •   Nov 27, 2015 12:13 UTC

Chr. Hansen DVS® FRESCO® 1000NG

Chr. Hansen DVS® FRESCO® 1000NG

Documents   •   Oct 30, 2015 08:00 UTC

L. CASEI 431® Selected summaries

L. CASEI 431® Selected summaries

Documents   •   May 21, 2015 06:57 UTC

This binder provides you with summaries of selected publications on Lactobacillus paracasei subsp. paracasei L. casei 431®.

L. CASEI 431® Handout

L. CASEI 431® Handout

Documents   •   May 21, 2015 06:57 UTC

Chr. Hansen offers multiple application forms of one of our most clinically documented Probio-Tec® strains, Lactobacillus L. casei 431®.

Contacts View all 5 hits

  • Commercial Development Manager
  • DKpaJSucY@jbchmbr-ujhawonsymenha.ccmomim
  • +45 25 46 10 07

  • Regional Communications Partner
  • UStuALepNOzs@cuthrvd-hbpanpqseygn.ofcosrmrp
  • +14146075862

  • Head of Investor Relations
  • dklbmauuripf@cruhrwu-hpdanjhseovn.zfcoowmqs
  • +4553392250
Head of Investor Relations

  • Regional Communications Partner
  • APAC
  • SGmiCHubONkc@crrhrby-hwfanjxsehpn.uqcozrm jz
  • +6597433100